Top Markets
#1 Official Trump Official Trump +37.23%
#2 Siacoin Siacoin +22.82%
#3 Melania Meme Melania Meme +20.04%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.89%
#5 Pump.fun Pump.fun +19.64%
#6 Unit Pump Unit Pump +19.64%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.56%
#9 Wrapped POL Wrapped POL +17.44%
#10 Mubarak Mubarak +17.31%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Classement en actions #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Prix de l'action
$0.04959193
Dernière synchronisation: 2025-03-17
Capitalisation boursière
$79.94M
Changement (1 jour)
13.49%
Changement (1 an)
0.00%
Pays
SE
Échange Abliva AB (publ) (ABLI)

Catégorie

Healthcare
Historique du prix de l'action pour Abliva AB (publ) (ABLI)
Prix de clôture le plus élevé : $0.04 le 2025-03-01

Prix de clôture le plus bas : $0.44 le 2008-10-01
Historique du prix de l'action de Abliva AB (publ) de 2008 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 83.38%
2024 -0.37%
2023 44.87%
2022 -73.02%
2021 -34.26%
2020 -30.47%
2019 -20.24%
2018 -46.40%
2017 4.60%
2016 -62.61%
2015 -86.83%
2014 208.88%
2013 -8.57%
2012 59.62%
2011 -55.60%
2010 208.76%
2009 91.09%
2008 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH